494
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Investigation of predictors for in-hospital death or long-term hospitalization in community-acquired pneumonia with risk factors for aspiration

, ORCID Icon, , , , , , , , , , & show all
Article: 2335721 | Received 03 Oct 2023, Accepted 22 Mar 2024, Published online: 04 Apr 2024

References

  • Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200–9. doi: 10.1016/S0140-6736(19)32989-7
  • Gupte T, Knack A, Cramer JD. Mortality from aspiration pneumonia: incidence, trends, and risk factors. Dysphagia. 2022;37(6):1493–1500. doi: 10.1007/s00455-022-10412-w
  • Teramoto S, Yoshida K, Hizawa N. Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia. Respir Investig. 2015;53(5):178–184. doi: 10.1016/j.resinv.2015.01.003
  • Lanspa MJ, Peyrani P, Wiemken T, et al. Characteristics associated with clinician diagnosis of aspiration pneumonia: a descriptive study of afflicted patients and their outcomes. J Hosp Med. 2015;10(2):90–96. doi: 10.1002/jhm.2280
  • Ito I, Kadowaki S, Tanabe N, et al. Tazobactam/Piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin. Pulm Pharmacol Ther. 2010;23(5):403–410. doi: 10.1016/j.pupt.2010.05.007
  • Hamao N, Ito I, Konishi S, et al. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial. BMC Pulm Med. 2020;20(1):1–11. doi: 10.1186/s12890-020-01198-4
  • Oi I, Ito I, Tanabe N, et al. Cefepime vs. meropenem for moderate-to-severe pneumonia in patients at risk for aspiration: an open-label, randomized study. J Infect Chemother. 2020;26(2):181–187. doi: 10.1016/j.jiac.2019.08.005
  • Komiya K, Rubin BK, Kadota JI, et al. Prognostic implications of aspiration pneumonia in patients with community acquired pneumonia: a systematic review with meta-analysis. Sci Rep. 2016;6(1):1–2. doi: 10.1038/srep38097
  • El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med. 2003;167(12):1650–1654. doi: 10.1164/rccm.200212-1543OC
  • Taylor JK, Fleming GB, Singanayagam A, et al. Risk factors for aspiration in community-acquired pneumonia: analysis of a hospitalized UK cohort. Am J Med. 2013;126(11):995–1001. doi: 10.1016/j.amjmed.2013.07.012
  • Covinsky KE, Pierluissi E, Johnston CB. Hospitalization-associated disability ‘she was probably able to ambulate, but i’m not sure.’ JAMA. 2011;306(16):1782–1793. doi: 10.1001/jama.2011.1556
  • Priefer BA, Robbins JA. Eating changes in mild-stage Alzheimer’s disease: a pilot study. Dysphagia. 1997;12(4):212–221. doi: 10.1007/PL00009539
  • Leopold NA, Kagel MC. Pharyngo-esophageal dysphagia in Parkinson’s disease. Dysphagia. 1997;18:11–18. doi: 10.1007/PL00009512
  • Thomas FJ, Wiles CM. Dysphagia and nutritional status in multiple sclerosis. J Neurol. 1999;246(8):677–682. doi: 10.1007/s004150050431
  • Enzinger PC, Mayer RJ. Esophageal cancer. Ann Cardiothorac Surg. 2017;6(2):190. doi: 10.21037/acs.2017.03.01
  • Vonghia L, Leggio L, Ferrulli A, et al. Acute alcohol intoxication. Eur J Intern Med. 2008;19(8):561–567. doi: 10.1016/j.ejim.2007.06.033
  • Adnet F, Baud F. Relation between Glasgow coma scale and aspiration pneumonia. Lancet. 1996;348(9020):123–124. doi: 10.1016/S0140-6736(05)64630-2
  • DeLegge MH. Aspiration pneumonia: incidence, mortality, and at-risk populations. J Parenter Enter Nutr. 2002;26(6 Suppl):S19–S25. doi: 10.1177/014860710202600604
  • Langmore SE, Terpenning MS, Schork A, et al. Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia. 1998;13(2):69–81. doi: 10.1007/PL00009559
  • Gomes GF, Pisani JC, Macedo ED, et al. The nasogastric feeding tube as a risk factor for aspiration and aspiration pneumonia. Curr Opin Clin Nutr Metab Care. 2003;6(3):327–333. doi: 10.1097/01.mco.0000068970.34812.8b
  • Bone DK, Davis JL, Zuidema GD, et al. Aspiration pneumonia. Ann Thorac Surg. 1974;18(1):30–37. doi: 10.1016/s0003-4975(10)65714-1
  • Noguchi S, Yatera K, Kato T, et al. Impact of the number of aspiration risk factors on mortality and recurrence in community-onset pneumonia. Clin Interv Aging. 2017;12:2087–2094. doi: 10.2147/CIA.S150499
  • Jones J. Risk and outcome of aspiration pneumonia in a city hospital. J Natl Med Assoc. 1993;85(7):533–536.
  • Oi I, Ito I, Tanabe N, et al. Protein C activity as a potential prognostic factor for nursing home-acquired pneumonia. PloS One. 2022;17(10):e0274685. doi: 10.1371/journal.pone.0274685
  • Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344(9):665–671. doi: 10.1056/NEJM200103013440908
  • Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250. doi: 10.1056/NEJM199701233360402
  • Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2019;200(7):E45–E67.
  • Lanspa MJ, Jones BE, Brown SM, et al. Mortality, morbidity, and disease severity of patients with aspiration pneumonia. J Hosp Med. 2013;8(2):83–90. doi: 10.1002/jhm.1996
  • Lim WS, Van Der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
  • Teramoto S, Fukuchi Y, Sasaki H, et al. High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan. J Am Geriatr Soc. 2008;56(3):577–579. doi: 10.1111/j.1532-5415.2008.01597.x
  • Lindenauer PK, Strait KM, Grady JN, et al. Variation in the diagnosis of aspiration pneumonia and association with hospital pneumonia outcomes. Ann Am Thorac Soc. 2018;15(5):562–569. doi: 10.1513/AnnalsATS.201709-728OC
  • Bosch X, Formiga F, Cuerpo S, et al. Aspiration pneumonia in old patients with dementia. Prognostic factors of mortality. Eur J Intern Med. 2012;23(8):720–726. doi: 10.1016/j.ejim.2012.08.006
  • Komiya K, Ishii H, Umeki K, et al. Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: a multicenter retrospective cohort study. Respirology. 2013;18(3):514–521. doi: 10.1111/resp.12029
  • Shirata M, Ito I, Ishida T, et al. Development and validation of a new scoring system for prognostic prediction of community-acquired pneumonia in older adults. Sci Rep. 2021;11(1):1–10. doi: 10.1038/s41598-021-03440-3
  • Cillóniz C, Dominedò C, Pericàs JM, et al. Community-acquired pneumonia in critically ill very old patients: a growing problem. Eur Respir Rev. 2020;29(155):1–15. doi: 10.1183/16000617.0126-2019
  • Cilloniz C, Ceccato A, San Jose A, et al. Clinical management of community acquired pneumonia in the elderly patient. Expert Rev Respir Med. 2016;10(11):1211–1220. doi: 10.1080/17476348.2016.1240037
  • Hayashi M, Iwasaki T, Yamazaki Y, et al. Clinical features and outcomes of aspiration pneumonia compared with non-aspiration pneumonia: a retrospective cohort study. J Infect Chemother. 2014;20(7):436–442. doi: 10.1016/j.jiac.2014.04.002
  • Momosaki R, Yasunaga H, Matsui H, et al. Predictive factors for oral intake after aspiration pneumonia in older adults. Geriatr Gerontol Int. 2016;16(5):556–560. doi: 10.1111/ggi.12506